ADC Therapeutics SA Shareholders' Equity
ADC Therapeutics SA (ADCT) had Shareholders' Equity of -$228.21 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent -$228.21M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$216.38M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$185.83M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$238.18M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | -$228.21M 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$216.38M 10-Q · filed 2026-08-13 |
| 2025-12-31 | -$185.83M 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$238.18M 10-Q · filed 2025-11-10 |
| 2025-06-30 | -$199.18M 10-Q · filed 2026-08-13 |
| 2025-03-31 | -$238.22M 10-Q · filed 2026-08-13 |
| 2024-12-31 | -$202.64M 10-Q · filed 2026-08-13 |
| 2024-09-30 | -$171.95M 10-Q · filed 2025-11-10 |
| 2024-06-30 | -$131.67M 10-Q · filed 2025-11-10 |
| 2024-03-31 | -$194.45M 10-Q · filed 2025-08-12 |
| 2023-12-31 | -$148.25M 10-K · filed 2026-03-10 |
| 2023-09-30 | -$64.25M 10-Q · filed 2024-11-07 |
| 2023-06-30 | -$19.70M 10-Q · filed 2024-11-07 |
| 2023-03-31 | $28.42M 10-Q · filed 2024-08-06 |
| 2022-12-31 | $79.45M 10-K · filed 2025-03-27 |
| 2021-12-31 | $154.03M 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |